Florida has seen a significant increase in legal claims related to dental damage allegedly caused by Suboxone use. This uptick can be attributed to several factors:

• Growing awareness of the potential link between Suboxone and tooth decay

• Increased use of Suboxone for opioid addiction treatment in Florida

• More patients discovering dental issues during routine check-ups and connecting them to their Suboxone use

As the opioid crisis continues to affect Florida communities, pharmaceutical companies have developed products like Suboxone to address opioid dependence. While Suboxone is considered effective for treating opioid use disorder, concerns about its dental side effects have emerged.

It's important to note that as of July 2024, there are hundreds of Suboxone tooth decay lawsuits pending in multidistrict litigation. While no court-approved settlements have been announced yet, the growing number of cases suggests this issue is gaining significant attention.

If you're a Florida resident who has used Suboxone and experienced unexpected dental issues, Furdock Law can provide the legal support you need. We understand the unique challenges these cases present and are committed to helping you navigate the legal process while seeking fair compensation for your dental injuries. Remember, in Florida, it's crucial to act promptly as there are time limits for filing such claims. Our team at Furdock Law is here to evaluate your case and guide you through every step of the legal journey, ensuring your rights are protected under Florida law.

Suboxone is a prescription medication that plays a crucial role in helping individuals in Florida who are grappling with opioid addiction and dependency. This medication is administered as a thin film that dissolves under the tongue, allowing for efficient absorption into the body. It's important to note that Suboxone is specifically designed and approved for the treatment of opioid use disorder (OUD).

In Florida, where opioid addiction remains a significant concern, Suboxone offers real relief for those battling OUD. However, it's essential to understand that Suboxone is most effective when used as part of a comprehensive treatment program. This approach typically includes detoxification, counseling, and other forms of support to address the complex nature of opioid addiction.

While Suboxone can be highly beneficial, some patients may experience side effects such as nausea, headache, or constipation. Of particular concern is the potential for dental issues, including tooth decay. It's crucial for individuals using Suboxone to maintain open communication with their healthcare providers about any concerning symptoms or side effects.

It's important to note that the use of Suboxone and other medication-assisted treatments for OUD is supported by current medical research and guidelines. In Florida, healthcare providers must follow specific protocols when prescribing Suboxone, ensuring that patients receive appropriate care and monitoring.

Plaintiffs in Florida pursuing Suboxone lawsuits may seek various types of compensation, including economic, non-economic, and punitive damages. Here's an overview of each category:

• Economic Damages — These damages apply to the direct financial losses resulting from dental problems associated with Suboxone use. They may include fillings for cavities, dental surgery, and lost income from taking time off work to receive treatment or to recover.

• Non-Economic Damages — In addition to economic damages, plaintiffs may recover non-economic damages stemming from the use of Suboxone. For example, individuals might suffer anxiety, depression, or trauma related to their dental issues and the stress they cause. While it’s harder to calculate these damages because they are subjective, an attorney who is experienced with this type of case can provide you with an estimate of their value.

• Punitive Damages — While the courts rarely award punitive damages, they may do so if they find the defendants—Indivior, in this case—liable for gross negligence. Punitive damages may apply if the courts determine that Indivior was aware of or should have been aware of the dangers associated with Suboxone and failed to warn of and properly address them.

When seeking legal representation for a Suboxone-related lawsuit in Florida, it's crucial to find an attorney with the right expertise and experience. At Furdock Law, we specialize in product liability cases and are well-versed in handling complex pharmaceutical litigation.

Key factors to consider when selecting an attorney include:

• Experience with similar cases, particularly those involving pharmaceutical companies and product liability

• A proven track record of success in handling complex litigation

• Clear communication about costs and fee structures, preferably working on a contingency basis

• Familiarity with Florida laws and regulations, especially regarding the Florida Consumer Collection Practices Act (FCCPA)

At Furdock Law, we pride ourselves on our deep understanding of Florida's legal landscape and our commitment to providing personalized legal support tailored to your specific needs. We stay up-to-date with the latest developments in Suboxone litigation and are prepared to navigate the complexities of your case.

It's important to note that Florida has recently updated its statute of limitations for product liability cases. As of March 24, 2023, the time limit for filing most product liability claims has been reduced to two years. However, for injuries that occurred before this date, the previous four-year statute of limitations may still apply.

Furdock Law is actively pursuing cases related to Suboxone-induced dental issues in Florida. As of July 18, 2024, all individual federal lawsuits have been consolidated in the United States District Court for the Northern District of Ohio under Judge Philip Calabrese. This consolidation aims to streamline pretrial proceedings for Suboxone tooth decay claims.

It's important to note that the U.S. Food and Drug Administration (FDA) updated the warning label on prescription Suboxone film in June 2022. This change has significant implications for potential lawsuits:

• Cases in states with two-year statutes of limitations are being filed imminently

• After June 2024, new Suboxone lawsuits will primarily be viable in states with three-year or longer statutes of limitations

Florida's four-year statute of limitations provides an extended window for affected individuals to seek legal recourse. If you believe you've experienced dental issues related to Suboxone use, we encourage you to contact Furdock Law for a consultation. Our team is dedicated to providing the legal support you need in navigating these complex cases.

Recent reports have highlighted a growing issue for Florida residents prescribed Suboxone sublingual film for opioid addiction treatment. Long-term users have reported experiencing significant dental problems, raising concerns about the medication's impact on oral health.

‍

At Furdock Law, we understand the importance of proper medication use and its potential impacts on oral health. Here's some crucial information for individuals using sublingual buprenorphine/naloxone films in Florida:

Proper Administration

• Place the film under your tongue or in your cheek

• Allow 10-15 minutes for complete dissolution

• Avoid eating or drinking for 30-45 minutes after dissolution

Multiple Dose Instructions

• If taking 3+ films, allow the first two to dissolve before adding the third

• This process may extend oral exposure time to an hour or more

Oral Health Considerations

• The medication creates an acidic environment in your mouth

• Extended exposure may potentially affect tooth enamel

Recommended Precaution

• Rinse your mouth thoroughly with water after the recommended waiting period

• This helps neutralize acidity and protect your oral health

We at Furdock Law specialize in addressing your specific needs related to medication use and potential legal concerns in Florida. If you have questions about proper medication use or feel you weren't adequately informed about potential side effects, we're here to provide the legal support you need.

It's crucial to follow your healthcare provider's instructions and discuss any concerns about medication administration or side effects. If you believe there's been a failure to warn about potential risks under Florida law, our team at Furdock Law is prepared to evaluate your case and provide expert guidance.

Tooth decay is only one of many possible negative symptoms that can occur when using Suboxone, with patients also possibly suffering symptoms (potential side effects) such as:

• Severe tooth decay and dental erosion

• Broken or fractured teeth

• Gum injuries and recession

• Oral infections

• Chronic mouth pain

• Dry mouth (reduced saliva production)

• Nausea and vomiting

• Headaches

• Excessive sweating

• Numbness in the mouth

• Dizziness and fainting

• Concentration difficulties

The primary concern is that while many side effects were adequately disclosed, the risk of severe tooth decay was not properly communicated to patients and healthcare providers until recently. Indivior, the manufacturer of Suboxone, only added warnings about potential tooth decay to their product labeling in 2022.Suboxone received FDA approval for opioid use disorder (OUD) treatment in 2002. This means that for approximately two decades, patients were not informed about this significant potential side effect, which could have influenced their treatment decisions.

Current lawsuits against Indivior focus on this failure to warn about dental decay risks, rather than the mere existence of the side effect. The legal action alleges negligence in not providing crucial information that patients had a right to know.

If you or a loved one in Florida has experienced severe dental issues after using Suboxone, we encourage you to reach out to us for a consultation. We can help you understand your rights and potential legal options under Florida law.

In 2022, the FDA issued a warning about dental problems associated with buprenorphine medications that dissolve in the mouth, such as Suboxone. The FDA report highlighted significant oral issues including tooth decay, cavities, infections, and tooth loss among users.

‍

These dental problems have been reported even in individuals with no prior history of dental issues and those practicing good oral hygiene. Based on medical research and adverse event reports, the FDA established a connection between the sublingual form of buprenorphine and severe tooth decay and other dental problems.

As a result, the FDA now requires manufacturers to include a warning about these dental risks in the prescribing information and patient Medication Guide.

These dental issues can be painful and costly to treat. If you're experiencing such problems in Florida, it's crucial to consult with an experienced attorney who specializes in defective drug cases. At Furdock Law, we have extensive experience in handling complex pharmaceutical litigation and can provide the legal support you need.

Recent research published in JAMA in December 2022 suggests that sublingual film forms of buprenorphine are twice as likely to cause serious dental health issues compared to regular tablets. While the exact mechanism is still under investigation, these findings have prompted product liability attorneys to consider holding manufacturers accountable for potential health risks that may not have been adequately disclosed in warning labels.

It's important to note that while these dental risks are concerning, buprenorphine remains a crucial treatment option for opioid use disorder. The FDA emphasizes that the benefits of these medicines still outweigh the risks. We recommend consulting with medical professionals before making any decisions regarding your health or treatment plan.

The ongoing Suboxone lawsuits center on the claim that the manufacturer, Indivior, was aware of the potential dental risks associated with their product but failed to adequately warn users. The acidic nature of Suboxone sublingual tablets and films, which are administered under the tongue or on the cheek for extended periods, is believed to contribute to severe tooth decay and other oral health problems.

Key points in the Suboxone litigation include:

1. Early awareness: As far back as 2007, adverse event reports and medical studies suggested a link between Suboxone and dental decay.

2. Delayed action: Despite receiving at least 136 adverse event reports related to oral health issues between 2007 and 2021, Indivior allegedly chose not to act promptly.

3. Product transition: Around 2010, as patent protection for Suboxone tablets neared expiration, the manufacturer developed a film version and implemented pricing strategies to encourage patients to switch.

4. FDA warning: In January 2022, the FDA issued a final warning about serious dental issues associated with Suboxone's sublingual delivery method, prompting the addition of a warning label.

5. Ongoing patient suffering: Many patients experienced tooth decay, gum disease, and other dental problems for years before the warning was added.

The core of these lawsuits is the allegation that Indivior knew or should have known about Suboxone's potential for causing tooth decay but failed to warn healthcare providers and the public adequately.

If you're a Florida resident who has experienced dental issues after using Suboxone, Furdock Law is here to help. We specialize in navigating the complexities of such cases and can provide the legal support you need. Contact us for a consultation to discuss your specific situation and potential legal options.

Recent legal developments involving Indivior, the manufacturer of Suboxone, have raised concerns for Florida residents who may have been affected by the company's practices. In October 2023, Indivior agreed to a substantial $385 million settlement to resolve allegations of unfair monopolization of the Suboxone market. This followed earlier settlements of $102.5 million with multiple states, including Florida, and $30 million with health insurers over similar issues.

These legal actions stem from accusations that Indivior engaged in a practice known as "product hopping." This strategy allegedly involved rushing a new film version of Suboxone to market just as their patent on Suboxone tablets was expiring. Critics argue this was an attempt to maintain market dominance and prevent generic competition, potentially leading to higher costs for Florida consumers and healthcare systems.

Of particular concern to Florida residents is the ongoing litigation regarding severe tooth decay allegedly caused by Suboxone sublingual films. This new formulation, introduced as the tablet patent expired, is now at the center of lawsuits claiming inadequate warnings about potential dental risks.  

If you're a Florida resident who has been affected by inaccurate credit reporting or other FCRA violations, Furdock Law is here to provide the legal support you need. Our expertise in FCRA cases allows us to advocate effectively for your rights and seek appropriate remedies.